Systematic Review
Published on 17 Sep 2024
The Current State of Inflammation-Related Research in Prostate Cancer: A Bibliometric Analysis and Systematic Review
in Genitourinary Oncology
Frontiers in Oncology
doi 10.3389/fonc.2024.1432857
Type at least 3 characters
1,531 articles
Articles
Original Research
Accepted on 16 Sep 2024
Predictive Diagnostic Value of Mean Platelet Volume to Platelet Count and Neutrophil to Lymphocyte Ratios in the Gray Zone of Prostate Cancer with tPSA between 4 to 10 ng/mL
in Genitourinary Oncology
Frontiers in Oncology
doi 10.3389/fonc.2024.1454124
Original Research
Accepted on 16 Sep 2024
Risk factors of renal function deterioration after radical nephroureterectomy for upper tract urothelial carcinoma
in Genitourinary Oncology
Frontiers in Oncology
doi 10.3389/fonc.2024.1438835
Case Report
Accepted on 16 Sep 2024
Acute Pancreatitis and Biliary Obstruction from Metastatic Lymph Node Compression During [ 177 Lu] Lu-PSMA-617 Therapy: A Case Report
in Genitourinary Oncology
Frontiers in Oncology
doi 10.3389/fonc.2024.1442293
Systematic Review
Published on 16 Sep 2024
Efficacy and safety of the first-line systemic treatments in patients with advanced-stage urothelial carcinoma: A systematic review and network meta-analysis
in Genitourinary Oncology
Frontiers in Oncology
doi 10.3389/fonc.2024.1468784
- 130 views
Hypothesis and Theory
Accepted on 13 Sep 2024
Deciphering the Molecular Heterogeneity of Intermediate- and (Very-)High-Risk Non-Muscle-Invasive Bladder Cancer by Using Multi-Layered -Omics Studies
in Genitourinary Oncology
Frontiers in Oncology
doi 10.3389/fonc.2024.1424293
Original Research
Accepted on 13 Sep 2024
Evaluation of prognostic factors for late recurrence in clear cell renal carcinoma: an institutional study
in Genitourinary Oncology
Frontiers in Oncology
doi 10.3389/fonc.2024.1446953
Editorial
Accepted on 11 Sep 2024
Editorial: Bladder Preservation Options for Bladder Cancer
in Genitourinary Oncology
Frontiers in Oncology
doi 10.3389/fonc.2024.1493854
Original Research
Accepted on 09 Sep 2024
Development and validation of a simulation training platform for the ligation of deep dorsal vein complex in radical prostatectomy
in Genitourinary Oncology
Frontiers in Oncology
doi 10.3389/fonc.2024.1407393
Original Research
Accepted on 09 Sep 2024
Empowering Patients: How Accurate and Readable are Large Language Models in Renal Cancer
in Genitourinary Oncology
Frontiers in Oncology
doi 10.3389/fonc.2024.1457516
Review
Published on 09 Sep 2024
Biology-guided Radiotherapy (BgRT) in metastatic prostate cancer: time to push the envelope?
in Genitourinary Oncology
Frontiers in Oncology
doi 10.3389/fonc.2024.1455428
- 440 views
Case Report
Accepted on 05 Sep 2024
Case Report: Toripalimab plus Anlotinib in Postoperative Recurrent Renal Pelvic Sarcomatoid Urothelial Carcinoma
in Genitourinary Oncology
Frontiers in Oncology
doi 10.3389/fonc.2024.1397855
Case Report
Published on 05 Sep 2024
Case Report: Two Cases of Prostate Adenocarcinoma Progressing to Rare Sarcomatoid Carcinoma with Normal PSA Levels Following Endocrine Therapy
in Genitourinary Oncology
Frontiers in Oncology
doi 10.3389/fonc.2024.1456390
- 275 views
Original Research
Published on 04 Sep 2024
Intracorporeal urinary diversion offers the advantage of delaying postoperative renal function injury in patients undergoing robot-assisted radical cystectomy
in Genitourinary Oncology
Frontiers in Oncology
doi 10.3389/fonc.2024.1435050
- 172 views
Original Research
Accepted on 03 Sep 2024
Lifestyle and risk factors associated with elevated prostate-specific antigen levels in rural men: Implications for health counseling.
in Genitourinary Oncology
Frontiers in Oncology
doi 10.3389/fonc.2024.1451941
Systematic Review
Published on 03 Sep 2024
Diagnostic Accuracy of Cytology and Urine Methylation Test in Patients with Non-Muscle Invasive Bladder Cancer: A Systematic Review and Meta-Analysis
in Genitourinary Oncology
Frontiers in Oncology
doi 10.3389/fonc.2024.1412346
- 235 views